Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | fatty acid elongase, putative | 0.008 | 0 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0614 | 0.6634 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0885 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.008 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0822 | 0.9226 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0614 | 0.6634 | 0.5 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.0614 | 0.6634 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.008 | 0 | 0.5 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0614 | 0.6634 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.008 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.008 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = -111 nA | Electrophysiological activity(nA) of the compound was measured in rats | ChEMBL. | 11784131 |
ND (binding) | 0 | 50% inhibitory concentration against Neuronal nitric oxide synthase (nNOS) activity; ND is No Data | ChEMBL. | 11784131 |
nNOS activity (binding) | = 87.24 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-7 (M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 87.24 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-7 (M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 92.65 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-11 (M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 92.65 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-11 (M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 95.72 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-3 (M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 95.72 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-3 (M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 100 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 0(M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 100 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 0(M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 100.07 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-9 (M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 100.07 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-9 (M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 102.9 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-5 (M) | ChEMBL. | 11784131 |
nNOS activity (binding) | = 102.9 % | Neuronal subtype of Neuronal nitric oxide synthase (nNOS) activity tested on Rat Striatal neurones at the concentration of 10e-5 (M) | ChEMBL. | 11784131 |
S | 0 | Solubility (3% ethanol:water or 3% methanol:water) | ChEMBL. | 11784131 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.